Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-hodgkin Lymphoma, B Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00864942
What this trial is testing

Trial of Bendamustine, Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
Chronic Lymphocytic LeukemiaNon-Hodgkin's Lymphoma
Georgetown University 28
Early research (Phase 1)Study completedNCT00614042
What this trial is testing

Phase 1/1b Study of TRU-016 in Patients With Previously Treated CLL or Select Subtypes of Non-Hodgkin's Lymphoma

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Non-Hodgkin's Lymphoma (NHL)
Aptevo Therapeutics 96
Testing effectiveness (Phase 2)Study completedNCT03097770
What this trial is testing

Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD20

Who this might be right for
Hematopoietic/Lymphoid CancerAdult Acute Lymphoblastic Leukemia in RemissionB-cell Adult Acute Lymphoblastic Leukemia+20 more
Chinese PLA General Hospital 100
Large-scale testing (Phase 3)Ended earlyNCT03670901
What this trial is testing

Compare the Efficacy and Safety of JHL1101 Versus Rituximab in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL)

Who this might be right for
Diffuse Large B-Cell Lymphoma
JHL Biotech, Inc. 8
Testing effectiveness (Phase 2)WithdrawnNCT02228512
What this trial is testing

Study of Pomalidomide Combined With Modified DA-EPOCH and Rituximab in KSHV-Associated Lymphomas

Who this might be right for
Large Cell Lymphoma Arising in KSHV-associated Multicentric Castleman DiseasePrimary Effusion Lymphoma
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT06517511
What this trial is testing

Selinexor in Combination With R-CHOP as the First-line Therapy for TP53-mutated DLBCL Patients (Smart Trial)

Who this might be right for
Diffuse Large B Cell Lymphoma
Sun Yat-sen University 42
Not applicableStudy completedNCT06031194
What this trial is testing

Pharmacogenomics Effects on High-Dose Methotrexate Clearance in Patients With Diffuse Large B-Cell Lymphoma

Who this might be right for
Central Nervous System LymphomaDiffuse Large B-Cell Lymphoma
Ohio State University Comprehensive Cancer Center 20
Not applicableApproved For MarketingNCT04162756
What this trial is testing

Study of Brexucabtagene Autoleucel (KTE-X19) for the Treatment of Individuals With Relapsed/Refractory B-Cell Malignancies

Who this might be right for
Relapse/Refractory Mantle Cell Lymphoma
Kite, A Gilead Company
Large-scale testing (Phase 3)Not Yet RecruitingNCT06573645
What this trial is testing

A Phase III Clinical Trial of High-dose Rituximab (500mg/m²) Combined With CHOP Regimen in the Treatment of Male Patient With Newly Diagnosed Advanced DLBCL

Who this might be right for
Lymphoma, Large B-Cell, Diffuse
Xia Yi 428
Large-scale testing (Phase 3)Active Not RecruitingNCT03206671
What this trial is testing

Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents

Who this might be right for
Mature B-cell Non-Hodgkin Lymphoma
University Hospital Muenster 650
Testing effectiveness (Phase 2)Study completedNCT01431209
What this trial is testing

Ruxolitinib Phosphate to Treat Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin Lymphoma After Stem Cell Transplant

Who this might be right for
Recurrent Diffuse Large B-Cell LymphomaRecurrent Mature T- and NK-Cell Non-Hodgkin LymphomaRefractory Diffuse Large B-Cell Lymphoma+1 more
University of Nebraska 71
Large-scale testing (Phase 3)Active Not RecruitingNCT04628494
What this trial is testing

Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)

Who this might be right for
Diffuse Large B-cell Lymphoma
Genmab 483
Testing effectiveness (Phase 2)Looking for participantsNCT06682130
What this trial is testing

Glofitamab Bridging ASCT for Patients With Relapsed or Refractory DLBCL

Who this might be right for
Diffuse Large B-cell Lymphoma(DLBCL)
The First Affiliated Hospital of Soochow University 40
Very early researchWithdrawnNCT05015972
What this trial is testing

UCAR-T for CD19+ Refractory/Relapsed B Hematologic Malignancies

Who this might be right for
B-cell Lymphoma
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
Not applicableStudy completedNCT05349201
What this trial is testing

CAR T Cells Real World Evidence Study Based on the French Hospital Claims Data Source (PMSI)

Who this might be right for
Diffuse Large B-Cell Lymphoma (DLBCL)Acute Lymphoblastic Leukemia (ALL)
Novartis Pharmaceuticals 273
Not applicableStudy completedNCT05541328
What this trial is testing

Comparison of Clinical Outcomes Among Patients Treated With Tisagenlecleucel

Who this might be right for
Diffuse Large B-cell Lymphoma
Novartis Pharmaceuticals 169
Early research (Phase 1)Study completedNCT03263637
What this trial is testing

Study to Assess Safety, Tolerability, Pharmacokinetics and Antitumor Activity of AZD4573 in Relapsed/Refractory Haematological Malignancies

Who this might be right for
Relapsed or Refractory Haematological Malignancies IncludingAcute Myeloid LeukemiaAcute Lymphocytic Leukemia+8 more
AstraZeneca 44
Testing effectiveness (Phase 2)Study completedNCT00064311
What this trial is testing

Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
National Institutes of Health Clinical Center (CC)
Testing effectiveness (Phase 2)Active Not RecruitingNCT02981628
What this trial is testing

Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia

Who this might be right for
Recurrent B Acute Lymphoblastic LeukemiaRecurrent B Lymphoblastic LymphomaRefractory B Acute Lymphoblastic Leukemia+1 more
Children's Oncology Group 80
Large-scale testing (Phase 3)Not Yet RecruitingNCT06355401
What this trial is testing

Maintenance Hormonal Therapy and DLBCL

Who this might be right for
Diffuse Large B Cell Lymphoma
Sohag University 100
Next Page